Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination
The diversity of vaccination modalities and infection history are both variables that have an impact on the immune memory of individuals vaccinated against SARS-CoV-2. To gain more accurate knowledge of how these parameters imprint on immune memory, we conducted a long-term follow-up of SARS-CoV-2 spike protein-specific immune memory in unvaccinated and vaccinated COVID-19 convalescent individuals as well as in infection-naïve vaccinated individuals. Here, we report that individuals from the convalescent vaccinated (hybrid immunity) group have the highest concentrations of spike protein-specific antibodies at 6 months after vaccination. As compared with infection-naïve vaccinated individuals, they also display increased frequencies of an atypical mucosa-targeted memory B cell subset. These individuals also exhibited enhanced TH1 polarization of their SARS-CoV-2 spike protein-specific follicular T helper cell pool. Together, our data suggest that prior SARS-CoV-2 infection increases the titers of SARS-CoV-2 spike protein-specific antibody responses elicited by subsequent vaccination and induces modifications in the composition of the spike protein-specific memory B cell pool that are compatible with enhanced functional protection at mucosal sites.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Science translational medicine - 15(2023), 687 vom: 15. März, Seite eade0550 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Barateau, Véronique [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies |
|---|
| Anmerkungen: |
Date Completed 20.03.2023 Date Revised 17.04.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1126/scitranslmed.ade0550 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354265695 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354265695 | ||
| 003 | DE-627 | ||
| 005 | 20231226061837.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1126/scitranslmed.ade0550 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1180.xml |
| 035 | |a (DE-627)NLM354265695 | ||
| 035 | |a (NLM)36921035 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Barateau, Véronique |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.03.2023 | ||
| 500 | |a Date Revised 17.04.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The diversity of vaccination modalities and infection history are both variables that have an impact on the immune memory of individuals vaccinated against SARS-CoV-2. To gain more accurate knowledge of how these parameters imprint on immune memory, we conducted a long-term follow-up of SARS-CoV-2 spike protein-specific immune memory in unvaccinated and vaccinated COVID-19 convalescent individuals as well as in infection-naïve vaccinated individuals. Here, we report that individuals from the convalescent vaccinated (hybrid immunity) group have the highest concentrations of spike protein-specific antibodies at 6 months after vaccination. As compared with infection-naïve vaccinated individuals, they also display increased frequencies of an atypical mucosa-targeted memory B cell subset. These individuals also exhibited enhanced TH1 polarization of their SARS-CoV-2 spike protein-specific follicular T helper cell pool. Together, our data suggest that prior SARS-CoV-2 infection increases the titers of SARS-CoV-2 spike protein-specific antibody responses elicited by subsequent vaccination and induces modifications in the composition of the spike protein-specific memory B cell pool that are compatible with enhanced functional protection at mucosal sites | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 650 | 7 | |a Antibodies |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
| 700 | 1 | |a Peyrot, Loïc |e verfasserin |4 aut | |
| 700 | 1 | |a Saade, Carla |e verfasserin |4 aut | |
| 700 | 1 | |a Pozzetto, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Brengel-Pesce, Karen |e verfasserin |4 aut | |
| 700 | 1 | |a Elsensohn, Mad-Hélénie |e verfasserin |4 aut | |
| 700 | 1 | |a Allatif, Omran |e verfasserin |4 aut | |
| 700 | 1 | |a Guibert, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Compagnon, Christelle |e verfasserin |4 aut | |
| 700 | 1 | |a Mariano, Natacha |e verfasserin |4 aut | |
| 700 | 1 | |a Chaix, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Djebali, Sophia |e verfasserin |4 aut | |
| 700 | 1 | |a Fassier, Jean-Baptiste |e verfasserin |4 aut | |
| 700 | 1 | |a Lina, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Lefsihane, Katia |e verfasserin |4 aut | |
| 700 | 1 | |a Espi, Maxime |e verfasserin |4 aut | |
| 700 | 1 | |a Thaunat, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Marvel, Jacqueline |e verfasserin |4 aut | |
| 700 | 1 | |a Rosa-Calatrava, Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Pizzorno, Andres |e verfasserin |4 aut | |
| 700 | 1 | |a Maucort-Boulch, Delphine |e verfasserin |4 aut | |
| 700 | 1 | |a Henaff, Laetitia |e verfasserin |4 aut | |
| 700 | 1 | |a Saadatian-Elahi, Mitra |e verfasserin |4 aut | |
| 700 | 1 | |a Vanhems, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Paul, Stéphane |e verfasserin |4 aut | |
| 700 | 1 | |a Walzer, Thierry |e verfasserin |4 aut | |
| 700 | 1 | |a Trouillet-Assant, Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a Defrance, Thierry |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Science translational medicine |d 2009 |g 15(2023), 687 vom: 15. März, Seite eade0550 |w (DE-627)NLM195151879 |x 1946-6242 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:687 |g day:15 |g month:03 |g pages:eade0550 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1126/scitranslmed.ade0550 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 687 |b 15 |c 03 |h eade0550 | ||